Bluejay Diagnostics BJDX Income Statement (2020-2026)

NASDAQ BJDX
$0.95 -0.01 (-1.26%)
At close: Aug 20, 2026 · 10:07 AM UTC
Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
329.00266.00630.00630.00630.00632.00639.00640.00774.00774.000.00M0.00M0.05M0.05M0.14M0.37M0.41M0.45M1.03M2.08M
Revenue & cost
Revenue (Quarter)
0.25M
Gross Profit (Quarter)
0.05M
Operating items
Research & Development (Quarter)
0.44M-0.40M0.05M0.76M1.38M1.32M1.35M1.68M1.40M1.29M1.33M1.03M0.55M0.55M0.78M0.89M0.79M0.59M0.81M1.44M
Selling, General & Administrative (Quarter)
0.45M0.82M1.32M1.20M0.15M0.96M0.15M1.07M0.96M1.10M1.09M0.86M0.81M0.93M1.10M1.10M0.83M0.88M1.13M0.91M
Other Operating Expenses (Quarter)
0.07M0.96M0.69M0.08M-0.21M0.17M1.18M0.15M-0.02M687.000.01M305.00753.00816.00
Operating Expenses (Quarter)
0.96M1.37M2.07M2.03M2.81M2.45M2.68M2.90M2.34M2.39M2.43M1.90M1.36M1.48M1.89M1.99M1.62M1.46M1.94M2.35M
Operating Income (Quarter)
-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.43M-1.90M-1.36M-1.48M-1.89M-1.99M-1.62M-1.46M-1.94M-2.35M
EBIT (Quarter)
-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.43M-1.90M-1.36M-1.48M-1.89M-1.99M-1.62M-1.46M-1.94M-2.35M
Non-operating items
Interest & Investment Income (Quarter)
0.03M0.02M0.06M0.04M0.02M0.03M0.02M0.03M0.02M0.02M
Other Non Operating Income (Quarter)
-0.00M0.06M0.00M0.14M0.09M0.04M-0.08M0.07M0.03M0.01M0.01M0.01M-275.00554.00579.00731.00282.00
Non Operating Income (Quarter)
-0.24M-0.09M0.05M0.05M-0.15M0.07M0.14M0.09M0.04M0.08M0.10M-0.58M-0.12M0.05M0.02M0.03M0.02M0.03M0.02M0.03M
Net income details
EBT (Quarter)
-1.69M-1.34M-2.10M-2.13M-2.91M-2.49M-2.72M-3.00M-2.35M-2.43M-2.44M-2.51M-1.49M-2.14M-1.91M-1.97M-1.60M-1.43M-2.02M-2.40M
Profit After Tax (Quarter)
-1.19M-1.46M-2.01M-1.94M-2.96M-2.39M-2.54M-2.81M-2.30M-2.30M-2.33M-2.48M-1.48M-1.43M-1.86M-1.96M-1.60M-1.43M-1.92M-2.32M
Income from Continuing Operations (Quarter)
-1.69M-1.34M-2.10M-2.13M-2.91M-2.49M-2.72M-3.00M-2.35M-2.43M-2.44M-2.51M-1.49M-2.14M-1.91M-1.97M-1.60M-1.43M-2.02M-2.40M
Consolidated Net Income (Quarter)
-1.69M-1.34M-2.10M-2.13M-2.91M-2.49M-2.72M-3.00M-2.35M-2.43M-2.44M-2.51M-1.49M-2.14M-1.91M-1.97M-1.60M-1.43M-2.02M-2.40M
Income towards Parent Company (Quarter)
-1.69M-1.34M-2.10M-2.13M-2.91M-2.49M-2.72M-3.00M-2.35M-2.43M-2.44M-2.51M-1.49M-2.14M-1.91M-1.97M-1.60M-1.43M-2.02M-2.40M
Net Income towards Common Stockholders (Quarter)
-1.69M-1.34M-2.10M-2.13M-2.91M-2.49M-2.72M-3.00M-2.35M-2.43M-2.44M-2.51M-14.71M-1.43M-1.91M-1.97M-1.60M-1.43M-2.02M-2.40M
Additional items
EPS (Basic) (Quarter)
-0.01M-0.01M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-307.77-31.23-13.79-5.67-4.06-3.18-2.05-2.44
EPS (Diluted) (Quarter)
-0.01M-0.01M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-307.77-31.23-13.79-5.67-4.06-3.18-2.05-2.44
Shares Outstanding (Quarter)
328.00266.00629.00630.00630.00630.00637.00639.00689.00685.000.00M0.00M0.05M0.05M0.14M0.35M0.39M0.45M0.98M0.98M
Shares Outstanding (Diluted) (Quarter)
328.00266.00629.00630.00630.00630.00637.00639.00689.00685.000.00M0.00M0.05M0.05M0.14M0.35M0.39M0.45M0.98M0.98M
EBITDA (Quarter)
-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.43M-1.90M-1.36M-1.48M-1.89M-1.99M-1.62M-1.46M-1.94M-2.35M
Interest Expenses (Quarter)
0.73M-0.03M0.03M0.14M0.10M0.04M0.04M0.10M0.01M0.04M0.04M0.63M0.19M0.69M0.04M0.01M0.01M187.000.10M0.07M